We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens.
- Authors
Cleary, Linda; Slattery, James; Bexis, Sotiria; Docherty, James R
- Abstract
We have previously demonstrated that contractions of rat vas deferens to exogenous noradrenaline involve predominantly alpha(1A)-adrenoceptors, but that contractions to endogenous noradrenaline involve predominantly alpha(1D)-adrenoceptors. In this study, we have examined the effects of sympathectomy on the subtypes of alpha(1)-adrenoceptor in rat vas deferens in radioligand binding and functional studies. In vehicle-treated tissues, antagonist displacement of [(3)H]prazosin binding to alpha(1)-adrenoceptors was consistent with a single population of alpha(1)-adrenoceptors. Binding affinities for a range of alpha(1)-adrenoceptor antagonists were expressed as pK(i) values and correlated with known affinities for alpha(1)-adrenoceptor subtypes. The correlation was significant only with alpha(1A)-adrenoceptors. In tissues from rats sympathectomised with 6-hydroxy-dopamine (2 x 100 mg kg(-1) i.p.), binding affinity for the alpha(1D)-adrenoceptor antagonist BMY 7378 fitted best with a two-site model. In functional studies, the potency of noradrenaline at producing total (phasic plus tonic) but not tonic contractions was increased in tissues from sympathectomised rats. Results obtained from sympathectomised rats suggest that phasic contractions are mainly alpha(1D)-adrenoceptor mediated, whereas tonic contractions are mainly alpha(1A)-adrenoceptor mediated, based on the effects of BMY 7378 and the alpha(1A)-adrenoceptor antagonist RS 100329. It is concluded that the predominant alpha(1)-adrenoceptor in vehicle-treated rat vas deferens is the alpha(1A)-adrenoceptor, both in terms of ligand binding and contractions to exogenous agonists. The alpha(1D)-adrenoceptor is only detectable by ligand binding following chemical sympathectomy, but is involved in noradrenaline-evoked contractions, particularly phasic contractions, of rat vas deferens.
- Subjects
VAS deferens physiology; IN vitro studies; ADRENERGIC alpha blockers; RESEARCH; SYMPATHECTOMY; NORADRENALINE; VAS deferens; ANIMAL experimentation; HETEROCYCLIC compounds; RESEARCH methodology; CELL receptors; EVALUATION research; MEDICAL cooperation; RATS; DOPAMINE; COMPARATIVE studies; DOSE-effect relationship in pharmacology; PHARMACODYNAMICS
- Publication
British Journal of Pharmacology, 2004, Vol 143, Issue 6, p745
- ISSN
0007-1188
- Publication type
journal article
- DOI
10.1038/sj.bjp.0705987